Teng Xue

机构：Shenyang Medical College, Harbin Medical University, Peking University, Third Affiliated Hospital of Harbin Medical University, Chengdu University, Heilongjiang Provincial Hospital, Education Department of Heilongjiang Province, Center for Life Sciences, China Medical University · ORCID：0000-0002-6933-4733

发表论文 18 篇 · 总被引 424 次 · h-index 10

代表论文

• Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells (2019 · Journal of Experimental & Clinical Cancer Research · 被引 113)
• PADI2‐Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1‐Mediated SOX2 mRNA Stability in Endometrial Cancer (2021 · Advanced Science · 被引 78)
• Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells (2025 · Immunity · 被引 33)
• XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells (2019 · Oncology Reports · 被引 33)
• HIV Tat protein inhibits hERG K+ channels: A potential mechanism of HIV infection induced LQTs (2011 · Journal of Molecular and Cellular Cardiology · 被引 31)
• NLRP3 Inflammasome Is Involved in Q-VD-OPH Induced Necroptosis Following Cerebral Ischemia-Reperfusion Injury (2018 · Neurochemical Research · 被引 29)